Matches in Nanopublications for { ?s <http://www.w3.org/2000/01/rdf-schema#label> ?o ?g. }
- context label "Children" assertion.
- association label "However, there are no sleep medications approved by the United States Food and Drug Administration and only one has been approved by the European Medicines Agency for pediatric insomnia; thus, most medications are prescribed off-label. Melatonin is widely used and safe in children with neurodevelopmental conditions. Gabapentin, clonidine, trazodone, and mirtazapine hold promise but require further study." assertion.
- association label "However, there are no sleep medications approved by the United States Food and Drug Administration and only one has been approved by the European Medicines Agency for pediatric insomnia; thus, most medications are prescribed off-label. Melatonin is widely used and safe in children with neurodevelopmental conditions. Gabapentin, clonidine, trazodone, and mirtazapine hold promise but require further study." assertion.
- context label "Children" assertion.
- cohort label "Adults" assertion.
- association label "Ketamine remains an off-label treatment for treatment-resistant depression with factors that limit widespread use including its dissociative effects and abuse potential." assertion.
- association label "This review summarize the present knowledge of IFN-β mechanism of action, the overall safety, and the short- and long-term efficacy of its use in relapsing remitting Multiple Sclerosis and clinically isolated syndromes" assertion.
- cohort label "Children and adolescents" assertion.
- association label "Paliperidone is FDA-approved for schizophrenia aged 12-17. However, the pharmacologic portfolio, extrapolation from adult studies, and the long track record of the parent drug, risperidone in child/adolescent psychiatric (CAP) population might expand its therapeutic potential. An 8-week open-label study [9] examined paliperidone monotherapy for acute mania, mixed, or hypomanic episode in pediatric patients (n = 15, 6–17 years of age) with bipolar spectrum disorders. At the end of follow-up period, 11 subjects (73%) completed the study; treatment with paliperidone was associated with a 60% response rate (50% decrease in the Young Mania Rating Scale) and 40% remission (YMRS <12)" assertion.
- spi label "https://doi.org/10.12688/f1000research.51018.1" assertion.
- obesity_together_With_metabolic_abnormality label "obesity together with metabolic abnormality" assertion.
- spi label "Obesity when accompanied by metabolic abnormality is closely associated with knee osteoarthritis." assertion.
- example-obesity-together-with-metabolic-abnormality label "obesity together with metabolic abnormality" assertion.
- mystatement label "All cats are gray" assertion.
- spi label "the protein TDP-43 generally contributes to the transcription of STMN2 in human motor neurons" assertion.
- relative-neocortex-size label "Relative size of the neocortex" assertion.
- spi label "the protein TDP-43 generally contributes to the transcription of STMN2 in human motor neurons" assertion.
- automatedDiscovery label "Automated Discovery" assertion.
- digital-humanities-research label "Digital Humanities Research" assertion.
- expression-of-genes-IRX3-and-IRX5 label "expression of genes IRX3 AND IRX5" assertion.
- spi label "A regulatory element within the first intron of FTO affects IRX3 and IRX5 expression during early adipogenesis" assertion.
- spi label "The OpenBiodiv knowledge graph contains semantic triples extracted from biodiversity literature" assertion.
- spi label "The latest release of the OpenBiodiv knowledge graph contains semantic triples extracted from biodiversity literature" assertion.
- license-with-non-commercial-clause label "license with a non-commercial clause" assertion.
- spi label "Glycocalyx bulk mechanically drives integrin clustering in cancer cells engaged with the extracellular matrix" assertion.
- STX1B-mutation label "STX1B mutation" assertion.
- spi label "Mutations in STX1B are associated with epilepsy" assertion.
- assertion label "test provenance template" assertion.
- integrin-clustering label "integrin clustering" assertion.
- patient_undergoing_PCI label "patient undergoing PCI" assertion.
- cost-effective_treatment label "cost-effective treatment" assertion.
- pharmacogenomics_guided_clopidogrel_therapy label "pharmacogenomics guided clopidogrel therapy" assertion.
- spi label "Adherence of a dataset to the FAIR Guiding Principles enables its automated discovery." assertion.
- ecm-bound-cancer-cell label "cancer cell engaged in extracellular matrix" assertion.
- glycocalyx-bulk label "glycocalyx bulk" assertion.
- spi label "In the context of Digital Humanities research, usage of the Linked Data Scopes ontology contributes to transparency of the research." assertion.
- release-of-openbiodiv-knowledge-graph label "A release of the OpenBiodiv knowledge graph" assertion.
- spi label "Triples in the OpenBiodiv knowledge graph releases are generally semantic triples extracted from biodiversity literature." assertion.
- spi label "NGLY1 deficiency is a novel autosomal recessive disorder of the ERAD pathway." assertion.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C2349975 label "enhanced" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0036667 label "sensitivity" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0549193 label "parameter" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0231491 label "antagonist" provenance.
- C0206058 label "elective surgeries" provenance.
- C0206058 label "elective surgeries" provenance.
- C0206058 label "elective surgeries" provenance.
- C0206058 label "elective surgeries" provenance.
- C0206058 label "elective surgeries" provenance.
- C0206058 label "elective surgical procedures" provenance.
- C0206058 label "elective surgical procedures" provenance.
- C0206058 label "elective surgical procedures" provenance.
- C0206058 label "elective surgical procedures" provenance.
- C0021485 label "injections" provenance.
- C0021485 label "injections" provenance.
- C0021485 label "injections" provenance.